title: Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis.
abstract: Extracellular levels of serotonin (5-HT), dopamine (DA) and their major metabolites 5-hydroxyindoleacetic acid (5-HIAA), 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA), were measured in the lateral hypothalamus of awake, freely moving rats using microdialysis combined with HPLC and electrochemical detection. To characterize the factors which control 5-HT release, the effects of various drugs were assessed. TTX had a reversible inhibitory effect on the basal levels of 5-HT, 5-HIAA, DOPAC and HVA. Infusion of K+ concomitantly increased 5-HT and DA and decreased 5-HIAA and HVA. Imipramine increased extracellular levels of 5-HT and DA and decreased 5-HIAA levels; this effect was TTX-sensitive. Systemic pargyline increased extracellular 5-HT and markedly decreased the metabolic levels. Pargyline pretreatment in the presence of imipramine, infused through the dialysis probe, slowly increased 5-HT levels above that produced by the reuptake blocker alone. Infusion with AMPH produced a dramatic, TTX-insensitive, increase in 5-HT and DA and a decrease in the metabolic levels. These results provide evidence that (1) basal release of 5-HT in the lateral hypothalamus results from neuronal activity, (2) the metabolites in the extracellular fluid derive primarily from intracellular monoamine oxidase (MAO) activity, (3) 5-HT is mainly removed from the extracellular space by a reuptake mechanism, with minimal contribution of an extracellular MAO, and (4) the AMPH-evoked release of 5-HT and DA is a Na+ channel-independent process.
authors.affiliation: Department of Anatomy, University of California San Francisco 94143.
authors.forename: F F
authors.initials: FF
authors.lastname: Matos
authors.forename: H
authors.initials: H
authors.lastname: Rollema
authors.forename: A I
authors.initials: AI
authors.lastname: Basbaum
mesh_terms: D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D003956:Dialysis / Q000379:methods; D007026:Hypothalamic Area, Lateral / Q000378:metabolism*; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D009043:Motor Activity; D018377:Neurotransmitter Agents / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013779:Tetrodotoxin / Q000494:pharmacology; D014851:Wakefulness
chemical_list: D001679:Biogenic Amines; D018377:Neurotransmitter Agents; D013779:Tetrodotoxin; D010293:Pargyline; D000661:Amphetamine; D007099:Imipramine; D011188:Potassium